551. A Multistate Investigation of Serious Adverse Events, Including Deaths, Following Ceftriaxone Injections, September 2024–June 2025
Authors
- Shaina Bernard
- Karen M. Landers
- Andrea Flinchum
- Christopher A. Czaja (ORCID: https://orcid.org/0000-0002-1742-514X)
- Mark Loh
- Juliet Stoltey
- Jenna N. Sinkevitch
- Carolyn Hembree
- Lauren Biehle (ORCID: https://orcid.org/0000-0003-1608-1290)
- Jason Mehr
- Brenda Brennan
- Marco Tori (ORCID: https://orcid.org/0000-0002-3352-536X)
- Trent Gulley
- Maya Beganovic
- Shannon B. Ruelle (ORCID: https://orcid.org/0000-0003-4758-7024)
- Rachana Bhattarai (ORCID: https://orcid.org/0000-0003-3100-2271)
- Cara Bicking Kinsey (ORCID: https://orcid.org/0000-0003-0004-5244)
- Scott T. Harris
- Rebecca Pierce (ORCID: https://orcid.org/0000-0002-7390-8744)
- Kimberly K. Garner
- Maribeth Sivilus
- Ramesh Gopalaswamy
- Stacy Tressler
- Douglas Thoroughman (ORCID: https://orcid.org/0000-0003-1150-1268)
- Christopher B. Wilson (ORCID: https://orcid.org/0000-0002-8481-7629)
- Kelley Garner
- Dat Tran
- Malakai Miller
- Allison G. Lafferty
- Melanie Roderick
- Argentina Charles
- Simone Godwin
- Melissa A Morrison
- JoAnna Wagner
- Shehzana Hussaini
- Andrea Salinas
- Joshua T Hoffner
- Haley Beeman
- Gargi Patel
- Jennifer Lind Lyles
- Grace Lee
- Dumbani Kayira
- Michael J Curran
- B S Biochemistry
- Andrew W Stubblefield
- Riley Moore
- Radhika Agarwal
- Kiran M Perkins
- Theresa Dulski
- Cullen Adre
- Liz Breitenstein
Institutions
- South Carolina Department of Health and Environmental Control (US)
- Louisiana State Department of Health and Hospitals (US)
- Indiana University Health (US)
- Centers for Disease Control and Prevention (US)
- Arizona Department of Health Services (US)
- Alabama Department of Public Health (US)
- Michigan Department of Health and Human Services (US)
- Virginia Department of Health (US)
- Pennsylvania Department of Health (US)
- United States Food and Drug Administration (US)
- Florida Department of Health (US)
- Colorado Department of Public Health and Environment (US)
- California Department of Public Health (US)
- New Jersey Department of Health (US)
- Oregon Health Authority (US)
- Harris Health System (US)
- Vermont State Hospital (US)
- Indiana State Department of Health (US)
- Vermont Department of Mental Health (US)
- Centers for Disease Control and Prevention (UG)
- Clear Creek Independent School District (US)
- The Centers (US)
- Tennessee Department of Health (US)
- Vermont Department of Health (US)
- Connecticut Department of Public Health (US)
- Georgia Department of Public Health (US)
- Kentucky Department for Public Health (US)
- Centers for Disease Control and Prevention (KE)
- Food and Drug Administration (TH)
- Arkansas Department of Health (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1093/ofid/ofaf695.024
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00